These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39138398)

  • 1. miR-223-5p serves as a diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI.
    Zhang S; Yang G; Chen Y; Liu W
    BMC Cardiovasc Disord; 2024 Aug; 24(1):423. PubMed ID: 39138398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating mir-483-5p as a novel diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI.
    Zhao Y; Song X; Ma Y; Liu X; Peng Y
    BMC Cardiovasc Disord; 2023 Jul; 23(1):360. PubMed ID: 37464313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention.
    Chen T; Zhang X; Qian W; Zhou R; Su M; Ma Y
    Bioengineered; 2022 Apr; 13(4):8266-8276. PubMed ID: 35302437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients.
    Zhang W; Chang G; Cao L; Ding G
    BMC Cardiovasc Disord; 2021 Feb; 21(1):74. PubMed ID: 33546604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes.
    Kasula S; Agarwal SK; Hacioglu Y; Pothineni NK; Bhatti S; Ahmed Z; Uretsky B; Hakeem A
    Heart; 2016 Dec; 102(24):1988-1994. PubMed ID: 27492942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome.
    Wang C; Liao P; Tang C; Chen C; Zhang X
    Front Endocrinol (Lausanne); 2024; 15():1423227. PubMed ID: 39257901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome.
    Wang C; Kong Y; Ding Y; Sun J; Chen T
    Med Sci Monit; 2019 Dec; 25():9517-9523. PubMed ID: 31834876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.
    Kong S; Chen C; Zheng G; Yao H; Li J; Ye H; Wang X; Qu X; Zhou X; Lu Y; Zhou H
    BMC Cardiovasc Disord; 2021 May; 21(1):253. PubMed ID: 34022791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA SNHG7 serves as a diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after percutaneous coronary intervention.
    Liao R; Han Q; Zhang L
    J Cardiothorac Surg; 2024 Jul; 19(1):450. PubMed ID: 39014478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Chen Y; Yin T; Xi S; Zhang S; Yan H; Tang Y; Qian J; Chen J; Su X; Du Z; Wang L; Qin Q; Gao C; Zheng Y; Zhao X; Cheng X; Li Z; Zhang W; Chen H; Wang J; Yang Z; Li H; Liu H; Zhou X; Qu B; Xiang D; Guo Y; Wang L; Nie S; Fu G; Yang M; Cai S
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1194-1204. PubMed ID: 31112635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of combining the SYNTAX score with reactive hyperemia index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    He Y; Cheng XF; Wang K; Liu T; Fan HP; Pan WX; He PX; Jin J
    Catheter Cardiovasc Interv; 2020 Apr; 95(5):E130-E139. PubMed ID: 31254447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of miR-486-5p, miR-451a, miR-21-5p and monocyte to high-density lipoprotein cholesterol ratio in patients with acute myocardial infarction.
    Xu L; Tian L; Yan Z; Wang J; Xue T; Sun Q
    Heart Vessels; 2023 Mar; 38(3):318-331. PubMed ID: 36214846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of miR-636 in patients with acute myocardial infarction undergoing percutaneous coronary intervention and its bioinformatics analysis.
    Wang Q; Tong Q; Jiang Z; Tang B
    J Cardiothorac Surg; 2024 Oct; 19(1):572. PubMed ID: 39354590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Murai T; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Hamaya R; Kanno Y; Lee T; Kakuta T
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1063-1074. PubMed ID: 29446567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Ma X; Shao Q; Dong L; Cheng Y; Lv S; Shen H; Liang J; Wang Z; Zhou Y
    Medicine (Baltimore); 2020 Jul; 99(30):e21321. PubMed ID: 32791726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Serum miR-186-5p With the Prognosis of Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention.
    Li Z; Wu J; Wei W; Cai X; Yan J; Song J; Wang C; Wang J
    Front Physiol; 2019; 10():686. PubMed ID: 31231239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.